Posts Tagged ‘Influenza’
UCSD Experts urge pregnant women? receive influenza vaccine
UCSD Expert Urge Pregnant Women To Receive Influenza Vaccine
The Organization of Teratology Information Specialists (OTIS), a non-profit organization based at the University of California, San Diego with affiliates across North America, urges pregnant women to receive the influenza vaccine as soon as possible. The recommendation comes shortly after the American College of Obstetricians and Gynecologists Committee on Obstetric Practice issued new …
Read more on Medical News Today
Related Blogs
Rates of health care workers against influenza vaccination increased 13 percent among participants in the Challenge of Joint Commission Resources “
Health Care Worker Flu Vaccination Rates Up 13 Percent Among Participants in Joint Commission Resources’ Challenge
Today, Joint Commission Resources announced the successful results of its second annual Flu Vaccination Challenge. Participating health care organizations reached a 76 percent flu vaccination average, a 13 percent increase over the average reported for last year’s challenge and 27 percent above the national average.
Read more on PR Newswire via Yahoo! Finance
Related Blogs
- Zipcar Challenges Car Owners to a 'Low-Car Diet' – PR Newswire …
- Bankrupted TV owes money to gameshow participants | ICT magazine
- Swine flu (H1N1): Symptoms, Diagnosis and Treatment | Bharat Chronicle
- Yahoo! Finance in Hong Kong gets a new look | Yodel Anecdotal
- Yahoo! Search Marketing Blog » Important Updates on Search Transitions
Inovio Biomedical H5N1 avian influenza DNA vaccine receives approval from Korea’s first clinical trials of
Inovio Biomedical H5N1 Avian Influenza DNA Vaccine Receives Korean Approval to Begin Clinical Trials
SAN DIEGO—-Inovio Biomedical Corporation , a leader in DNA vaccine design, development and delivery, announced today that its affiliate VGX International Inc. has received approval in Korea to begin a Phase I clinical trial in healthy volunteers for Inovio’s SynCon™ preventive DNA vaccine targeting H5N1 avian influenza.
Read more on Business Wire via Yahoo! Finance
Inovio Biomedical H5N1 Avian Influenza DNA Vaccine Receives Korean Approval to Begin Clinical Trials
Inovio Biomedical H5N1 Avian Influenza DNA Vaccine Receives Korean Approval to Begin Clinical Trials
SAN DIEGO—-Inovio Biomedical Corporation , a leader in DNA vaccine design, development and delivery, announced today that its affiliate VGX International Inc. has received approval in Korea to begin a Phase I clinical trial in healthy volunteers for Inovio’s SynCon™ preventive DNA vaccine targeting H5N1 avian influenza.
Read more on Business Wire via Yahoo! Finance

